A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia

被引：0
|
作者：
Amy Y. Wang
Howard Weiner
Margaret Green
Hua Chang
Noreen Fulton
Richard A. Larson
Olatoyosi Odenike
Andrew S. Artz
Michael R. Bishop
Lucy A. Godley
Michael J. Thirman
Satyajit Kosuri
Jane E. Churpek
Emily Curran
Kristen Pettit
Wendy Stock
Hongtao Liu
机构：
[1] University of Chicago Medicine,Internal Medicine/Pediatric Residency Program
[2] University of Chicago Medicine,Department of Medicine, Section of Hematology/Oncology
[3] Karyopharm Therapeutics Inc,Department of Medicine, Section of Hematology/Oncology
[4] University of Michigan Medicine,undefined
来源：
Journal of Hematology & Oncology | / 11卷
关键词：
AML; Selinexor; Induction chemotherapy; XPO1/CRM1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
    Wang, Amy Y.
    Weiner, Howard
    Green, Margaret
    Chang, Hua
    Fulton, Noreen
    Larson, Richard A.
    Odenike, Olatoyosi
    Artz, Andrew S.
    Bishop, Michael R.
    Godley, Lucy A.
    Thirman, Michael J.
    Kosuri, Satyajit
    Churpek, Jane E.
    Curran, Emily
    Pettit, Kristen
    Stock, Wendy
    Liu, Hongtao
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11 : 4
  • [2] Combination of Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML) Is Feasible and Tolerable
    Wang, Amy Y.
    Weiner, Howie Lawrence
    Green, Margaret
    Larson, Richard A.
    Odenike, Olatoyosi
    Artz, Andrew
    Godley, Lucy A.
    Thirman, Michael J.
    Churpek, Jane E.
    Curran, Emily K.
    Pettit, Kristen
    Stock, Wendy
    Liu, Hongtao
    [J]. BLOOD, 2016, 128 (22)
  • [3] Final Results from a Phase I Trial Combining Selinexor with High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in Acute Myeloid Leukemia (AML)
    Wang, Amy
    Weiner, Howard
    Larson, Richard A.
    Odenike, Olatoyosi
    Artz, Andrew S.
    Bishop, Michael R.
    Godley, Lucy
    Thirman, Michael
    Kosuri, Satyajit
    Churpek, Jane
    Curran, Emily K.
    Pettit, Kristen
    Stock, Wendy
    Liu, Hongtao
    [J]. BLOOD, 2018, 132
  • [4] A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
    Pardee, Timothy S.
    Anderson, Rebecca G.
    Pladna, Kristin M.
    Isom, Scott
    Ghiraldeli, Lais P.
    Miller, Lance D.
    Chou, Jeff W.
    Jin, Guangxu
    Zhang, Wei
    Ellis, Leslie R.
    Berenzon, Dmitriy
    Howard, Dianna S.
    Hurd, David D.
    Manuel, Megan
    Dralle, Sarah
    Lyerly, Susan
    Powell, Bayard L.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (09) : 2060 - 2073
  • [5] Induction chemotherapy with high-dose cytarabine and mitoxantrone in elderly acute myeloid leukemia (AML) patients.
    Ramanathan, Muthalagu
    Cerny, Jan
    Raffel, Glen
    Walsh, William Vincent
    Woda, Bruce
    Miron, Patricia
    Nath, Rajneesh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] High-dose cytarabine induction for acute myeloid leukemia
    Shepherd, JD
    Barnett, MJ
    Phillips, GL
    [J]. BLOOD, 1996, 88 (02) : 754 - 754
  • [7] PHASE-I CLINICAL AND PHARMACOKINETIC EVALUATION OF HIGH-DOSE MITOXANTRONE IN COMBINATION WITH CYTARABINE IN PATIENTS WITH ACUTE-LEUKEMIA
    FELDMAN, EJ
    ALBERTS, DS
    ARLIN, Z
    AHMED, T
    MITTELMAN, A
    BASKIND, P
    PENG, YM
    BAIER, M
    PLEZIA, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 2002 - 2009
  • [8] Idarubicin, high-dose cytarabine and etoposide for induction of remission in acute myeloid leukemia.
    Singhal, S
    Powles, R
    Treleaven, J
    Horton, C
    Hamblin, M
    Zomas, A
    Prendiville, J
    Saso, R
    Mackay, H
    Milan, S
    Mehta, J
    [J]. BLOOD, 1995, 86 (10) : 2039 - 2039
  • [9] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
    Bishop, JF
    Matthews, JP
    Young, GA
    Szer, J
    Gillett, A
    Joshua, D
    Bradstock, K
    Enno, A
    Wolf, MM
    Fox, R
    Cobcroft, R
    Herrmann, R
    VanDerWeyden, M
    Lowenthal, RM
    Page, F
    Garson, OM
    Juneja, S
    [J]. BLOOD, 1996, 87 (05) : 1710 - 1717
  • [10] A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia
    Cahill, Kirk E.
    Karimi, Yasmin H.
    Karrison, Theodore G.
    Jain, Nitin
    Green, Margaret
    Weiner, Howard
    Fulton, Noreen
    Kadri, Sabah
    Godley, Lucy A.
    Artz, Andrew S.
    Liu, Hongtao
    Thirman, Michael J.
    Le Beau, Michelle M.
    McNerney, Megan E.
    Segal, Jeremy
    Larson, Richard A.
    Stock, Wendy
    Odenike, Olatoyosi
    [J]. BLOOD ADVANCES, 2020, 4 (04) : 599 - 606
12345